Cross Country Healthcares, Inc. (NASDAQ: CCRN) on Tuesday, soared 0.33% from the previous trading day, before settling in for the closing price of $12.28. Within the past 52 weeks, CCRN’s price has moved between $12.00 and $23.64.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 28.45% over the last five years. The company achieved an average annual earnings per share of -76.82%. With a float of $31.92 million, this company’s outstanding shares have now reached $34.38 million.
The firm has a total of 2300 workers. Let’s measure their productivity. In terms of profitability, gross margin is 20.45%, operating margin of 1.83%, and the pretax margin is 1.05%.
Cross Country Healthcares, Inc. (CCRN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Cross Country Healthcares, Inc. is 5.58%, while institutional ownership is 102.59%. The most recent insider transaction that took place on Aug 02 ’24, was worth 33,473. In this transaction VP, Corporate Treasurer of this company sold 1,945 shares at a rate of $17.21, taking the stock ownership to the 7,605 shares. Before that another transaction happened on Aug 02 ’24, when Company’s Pres., Cross Country Locums sold 13,829 for $17.08, making the entire transaction worth $236,199. This insider now owns 24,696 shares in total.
Cross Country Healthcares, Inc. (CCRN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -76.82% per share during the next fiscal year.
Cross Country Healthcares, Inc. (NASDAQ: CCRN) Trading Performance Indicators
Cross Country Healthcares, Inc. (CCRN) is currently performing well based on its current performance indicators. A quick ratio of 3.07 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.26. Likewise, its price to free cash flow for the trailing twelve months is 2.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.70 in one year’s time.
Technical Analysis of Cross Country Healthcares, Inc. (CCRN)
Analysing the last 5-days average volume posted by the [Cross Country Healthcares, Inc., CCRN], we can find that recorded value of 0.69 million was better than the volume posted last year of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 24.90%. Additionally, its Average True Range was 0.56.
During the past 100 days, Cross Country Healthcares, Inc.’s (CCRN) raw stochastic average was set at 4.92%, which indicates a significant decrease from 14.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.47% in the past 14 days, which was lower than the 43.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.01, while its 200-day Moving Average is $16.60. Now, the first resistance to watch is $12.51. This is followed by the second major resistance level at $12.71. The third major resistance level sits at $12.85. If the price goes on to break the first support level at $12.17, it is likely to go to the next support level at $12.03. Now, if the price goes above the second support level, the third support stands at $11.83.
Cross Country Healthcares, Inc. (NASDAQ: CCRN) Key Stats
Market capitalization of the company is 416.54 million based on 34,774K outstanding shares. Right now, sales total 2,020 M and income totals 72,630 K. The company made 339,770 K in profit during its latest quarter, and -16,050 K in sales during its previous quarter.
